BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?

Sardanelli, 2010, Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group, Eur. J. Cancer, 46, 1296, 10.1016/j.ejca.2010.02.015 Warner, 2008, Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer, Ann. Intern. Med., 148, 671, 10.7326/0003-4819-148-9-200805060-00007 Houssami, 2008, Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer, J. Clin. Oncol., 26, 3248, 10.1200/JCO.2007.15.2108 Kuhl, 2007, Current status of breast MR imaging. Part 2. Clinical applications, Radiology, 244, 672, 10.1148/radiol.2443051661 Benndorf, 2010, Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes, Acta Radiol., 51, 715, 10.3109/02841851.2010.497164 Baltzer, 2010, False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study, AJR Am. J. Roentgenol., 194, 1658, 10.2214/AJR.09.3486 Edwards, 2013, Updates and revisions to the BI-RADS magnetic resonance imaging lexicon, Magn. Reson. Imaging Clin. N. Am., 21, 483, 10.1016/j.mric.2013.02.005 Chapellier, 2010, Quand classer une lésion BI-RADS 3 en IRM mammaire?, Imag. Femme, 20, 74, 10.1016/j.femme.2010.02.006 Mussurakis, 1996, Observer variability in the interpretation of contrast enhanced MRI of the breast, Br. J. Radiol., 69, 1009, 10.1259/0007-1285-69-827-1009 Stoutjesdijk, 2005, Variability in the description of morphologic and contrast enhancement characteristics of breast lesions on magnetic resonance imaging, Invest. Radiol., 40, 355, 10.1097/01.rli.0000163741.16718.3e de C. Moraes, 2010, Observer variability in the application of morphologic and dynamic criteria according to the BI-RADS for MRI, Breast J., 16, 558, 10.1111/j.1524-4741.2010.00968.x Fischer, 2004, Is the blooming sign a promising additional tool to determine malignancy in MR mammography?, Eur. Radiol., 14, 394, 10.1007/s00330-003-2055-9 Kuhl, 2000, Dynamic image interpretation of MRI of the breast, J. Magn. Reson. Imaging JMRI, 12, 965, 10.1002/1522-2586(200012)12:6<965::AID-JMRI23>3.0.CO;2-1 Heywang-Köbrunner, 2001, International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions, Eur. Radiol., 11, 531, 10.1007/s003300000745 Tardivon, 2007, Breast imaging and reporting data system (BIRADS): magnetic resonance imaging, Eur. J. Radiol., 61, 212, 10.1016/j.ejrad.2006.08.036 Veltman, 2008, Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions, Eur. Radiol., 18, 1123, 10.1007/s00330-008-0870-8 Baltzer, 2015, Lesion type and reader experience affect the diagnostic accuracy of breast MRI: a multiple reader ROC study, Eur. J. Radiol., 84, 86, 10.1016/j.ejrad.2014.10.023 Eby, 2009, Characteristics of probably benign breast MRI lesions, AJR Am. J. Roentgenol., 193, 861, 10.2214/AJR.08.2096 Eby, 2007, Cancer yield of probably benign breast MR examinations, J. Magn. Reson. Imaging JMRI, 26, 950, 10.1002/jmri.21123 Kuhl, 2000, Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results, Radiology, 215, 267, 10.1148/radiology.215.1.r00ap01267 Liberman, 2003, Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women, Cancer, 98, 377, 10.1002/cncr.11491 Lourenco, 2014, Probably benign breast MRI lesions: frequency, lesion type, and rate of malignancy, J. Magn. Reson. Imaging JMRI, 39, 789, 10.1002/jmri.24221 Sadowski, 2005, Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination, J. Magn. Reson. Imaging JMRI, 21, 556, 10.1002/jmri.20312 Weinstein, 2010, Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667, Radiology, 255, 731, 10.1148/radiol.10081712 Renz, 2008, Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study, Eur. Radiol., 18, 2370, 10.1007/s00330-008-1029-3 Dietzel, 2015, Magnetic resonance imaging of intraductal papillomas: typical findings and differential diagnosis, J. Comput. Assist. Tomogr., 39, 176, 10.1097/RCT.0000000000000188 Dietzel, 2010, Differential diagnosis of breast lesions 5mm or less: is there a role for magnetic resonance imaging?, J. Comput. Assist. Tomogr., 34, 456, 10.1097/RCT.0b013e3181d06b09 Fischer, 2005, Further signs in the evaluation of magnetic resonance mammography: a retrospective study, Invest. Radiol., 40, 430, 10.1097/01.rli.0000167138.52283.aa Baltzer, 2013, A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography, Eur. Radiol., 23, 2051, 10.1007/s00330-013-2804-3